Literature DB >> 26285894

Ureteric patency after Deflux® injection for the treatment of vesicoureteric reflux in children confirmed by a novel epidural catheter-assisted endoscopic technique.

Manabu Okawada1, Soichi Shibuya2, Takashi Doi2, Go Miyano2, Hiroyuki Koga2, Geoffrey J Lane2, Tadaharu Okazaki2, Atsuyuki Yamataka2.   

Abstract

PURPOSE: We present EDCAT (epidural catheter-assisted Deflux(®) treatment) for treating vesicoureteral reflux (VUR) and confirming ureteric patency after Deflux(®) treatment.
METHODS: We treated 147 ureters in 101 children (M:F 62:39; VUR ≤ grade III: n = 72; VUR ≥ grade IV: n = 75) using EDCAT between 2011 and 2014. EDCAT involves injecting 1-3 mL of diluted indigo carmine solution through an epidural anesthesia catheter inserted into the Deflux(®)-treated ureter and observing for up to 15 min to confirm patency.
RESULTS: For EDCAT, mean age was 4.9 years and mean operative time was 30.1 ± 12.1 min; overall cure of VUR after initial treatment was 87.7 % for VUR grades I-V, 88.9 % for VUR ≤ grade III, and 86.6 % for VUR ≥ grade IV; VUR was cured in 129/147 after 1 treatment, 7/18 after 2 treatments, 7/11 after 3 treatments, and persistent in 4/4. We experienced 1 case of obstruction after an EDCAT catheter was removed before confirming patency. EDCAT catheters were left overnight in 2 ureters in 2 cases when patency could not be confirmed after 15 min to prevent obstruction. Both did not develop obstruction. Four ureters with recurrence of VUR (all grade ≤ II) are being observed.
CONCLUSION: EDCAT allows ureteric patency to be confirmed immediately and prevents obstruction.

Entities:  

Keywords:  Deflux®; Epidural catheter; Vesicoureteral reflux

Mesh:

Substances:

Year:  2015        PMID: 26285894     DOI: 10.1007/s00383-015-3778-9

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  14 in total

1.  Dynamic hydrodistention classification of the ureter and the double hit method to correct vesicoureteral reflux.

Authors:  Wolfgang H Cerwinka; Hal C Scherz; Andrew J Kirsch
Journal:  Arch Esp Urol       Date:  2008-10       Impact factor: 0.436

2.  Current trends in dextranomer hyaluronic acid copolymer (Deflux) injection technique for endoscopic treatment of vesicoureteral reflux.

Authors:  Andrew J Kirsch; Angela M Arlen; Goran Lackgren
Journal:  Urology       Date:  2014-06-26       Impact factor: 2.649

Review 3.  Pediatric Vesicoureteral Reflux Guidelines Panel Summary Report: Clinical Practice Guidelines for Screening Siblings of Children With Vesicoureteral Reflux and Neonates/Infants With Prenatal Hydronephrosis.

Authors:  Steven J Skoog; Craig A Peters; Billy S Arant; Hillary L Copp; Jack S Elder; R Guy Hudson; Antoine E Khoury; Armando J Lorenzo; Hans G Pohl; Ellen Shapiro; Warren T Snodgrass; Mireya Diaz
Journal:  J Urol       Date:  2010-07-21       Impact factor: 7.450

Review 4.  Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children.

Authors:  Craig A Peters; Steven J Skoog; Billy S Arant; Hillary L Copp; Jack S Elder; R Guy Hudson; Antoine E Khoury; Armando J Lorenzo; Hans G Pohl; Ellen Shapiro; Warren T Snodgrass; Mireya Diaz
Journal:  J Urol       Date:  2010-07-21       Impact factor: 7.450

5.  Clinical and radiographic results of endoscopic injection for vesicoureteral reflux: defining measures of success.

Authors:  Jonathan D Kaye; Arun K Srinivasan; Christina Delaney; Wolfgang H Cerwinka; James M Elmore; Hal C Scherz; Andrew J Kirsch
Journal:  J Pediatr Urol       Date:  2011-05-04       Impact factor: 1.830

6.  Delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (Deflux) injection for treatment of vesicoureteral reflux in children: a case series.

Authors:  Peter C Rubenwolf; Anne-Karoline Ebert; Petra Ruemmele; Wolfgang H Rösch
Journal:  Urology       Date:  2013-03       Impact factor: 2.649

7.  Postoperative ureteral obstruction after endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer (Vantris®).

Authors:  Farshid Alizadeh; Hamid Mazdak; Mohammad H Khorrami; Pooyan Khalighinejad; Pourya Shoureshi
Journal:  J Pediatr Urol       Date:  2012-12-06       Impact factor: 1.830

8.  Modification of the sting procedure for vesicoureteral reflux: ureteral repositioning and injection.

Authors:  N Capozza; P Caione
Journal:  Arch Esp Urol       Date:  2008-03       Impact factor: 0.436

9.  Acute and delayed vesicoureteral obstruction after endoscopic treatment of primary vesicoureteral reflux with dextranomer/hyaluronic acid copolymer: why and how to manage.

Authors:  L García-Aparicio; J Rodo; P Palazon; O Martín; E Blázquez-Gómez; A Manzanares; N García-Smith; M Bejarano; I de Haro; J M Ribó
Journal:  J Pediatr Urol       Date:  2013-03-16       Impact factor: 1.830

10.  Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.

Authors:  Andrew J Kirsch; Marcos R Perez-Brayfield; Hal C Scherz
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.